SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $12,751,000 | -63.9% | 6,975,000 | -52.2% | 0.03% | -64.0% |
| Q3 2014 | $35,350,000 | -30.1% | 14,585,000 | -43.3% | 0.09% | +53.4% |
| Q2 2014 | $50,608,000 | +323.6% | 25,714,000 | +265.0% | 0.06% | +114.8% |
| Q1 2014 | $11,946,000 | +4.2% | 7,045,000 | -8.1% | 0.03% | +3.8% |
| Q4 2013 | $11,459,000 | +27.9% | 7,662,000 | +5.3% | 0.03% | +23.8% |
| Q3 2013 | $8,962,000 | -1.8% | 7,275,000 | -4.5% | 0.02% | 0.0% |
| Q2 2013 | $9,124,000 | – | 7,615,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |